Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Maximus Reports Fiscal Year 2023 First Quarter Results By: Maximus via Business Wire February 08, 2023 at 16:05 PM EST Raises FY23 Revenue and Earnings Guidance Following Scheduled Restart of Medicaid Redeterminations Maximus (NYSE: MMS), a leading provider of government services worldwide, reported financial results for the three months ended December 31, 2022. Highlights for the first quarter of fiscal year 2023 include: Revenue increased 8.5% to $1.25 billion, compared to $1.15 billion for the prior year period. Organic growth was 10.3% and driven by new or expanded programs in all three segments. Diluted earnings per share were $0.65, and adjusted diluted earnings per share were $0.94. The company is raising revenue and earnings guidance for fiscal year 2023 following the restart of Medicaid redeterminations scheduled to begin in the third quarter. Fiscal year 2023 revenue is now expected to range between $4.85 billion and $5.0 billion with adjusted diluted earnings per share between $4.00 and $4.30 per share. A quarterly cash dividend of $0.28 per share is payable on February 28, 2023, to shareholders of record on February 15, 2023. "We are pleased with our solid first quarter results which reflect good execution, and we expect continued momentum in fiscal 2023," said Bruce Caswell, President and Chief Executive Officer. "Our increased guidance for fiscal 2023 is significant as it represents a clearing of the last remaining pandemic-related headwind in our U.S. Services business. Restarting Medicaid redeterminations is an unprecedented undertaking and as a long-term public partner to government, we are poised to support our current customers and see solid demand for our capabilities across the broader Medicaid market." Caswell continued, "We are capitalizing on the organic growth potential of the core business and executing well on our recently refreshed strategy, including making definitive headway in the key areas of clinical services and technology modernization. The remainder of fiscal year 2023, underpinned by our stable business model, should see us continue to successfully capture the upside potential of in-demand government services." First Quarter Results Revenue for the first quarter of fiscal year 2023 increased 8.5% to $1.25 billion, compared to $1.15 billion for the prior year period, which was net of a 1.9% currency headwind. Organic growth was 10.3% from new or expanded programs in all three segments resulting from strong demand for the company's services. For the first quarter of fiscal year 2023, operating margin was 6.0% and the adjusted operating margin was 7.9%. This compares to margins of 7.1% and 9.0%, respectively, for the prior year period. Diluted earnings per share were $0.65 and adjusted diluted earnings per share were $0.94. This compares to $0.85 and $1.12, respectively, for the prior-year period which contained profitable short-term COVID response work in the domestic segments and had less interest expense due to a more favorable rate environment. U.S. Federal Services Segment U.S. Federal Services Segment revenue for the first quarter of fiscal year 2023 increased 6.2% to $618.2 million, compared to $581.9 million reported for the prior year period. All growth was organic and driven primarily by volume growth in the segment's clinical services business and an anticipated higher run rate on a large cost-plus contract. The segment operating margin for the first quarter of fiscal year 2023 was 8.3%, compared to 10.6% reported for the prior year, and in-line with company expectations. The full-year fiscal 2023 margin for the U.S. Federal Services Segment is still expected to range between 10% and 11%. U.S. Services Segment U.S. Services Segment revenue for the first quarter of fiscal year 2023 increased 13.7% to $439.5 million, compared to $386.4 million reported in the prior year period. All growth was organic and driven by previously disclosed new work in the core business areas of eligibility support and clinical services. The segment operating margin for the first quarter of fiscal year 2023 was 8.6%, compared to 14.1% reported for the prior year period, reflecting the headwind to the segment's profitability from the paused Medicaid redeterminations. The full-year fiscal 2023 margin for the U.S. Services Segment is expected to range between 9% and 11% with a lift to profitability expected later in the fiscal year due to the scheduled restart of redeterminations. Outside the U.S. Segment Outside the U.S. Segment revenue for the first quarter of fiscal year 2023 increased 4.9% to $191.6 million, compared to $182.6 million reported in the prior year period, which was net of a 12% currency headwind. Organic growth in the segment was approximately 16% driven primarily by the U.K. Restart Programme reaching full capacity. The segment operating income for the first quarter of fiscal year 2023 was $10.1 million, or 5.3% on a margin basis. This compares to an operating loss of $9.5 million in the prior year period due primarily to contracts with planned start-up losses, such as the U.K. Restart Programme. The full-year fiscal 2023 margin for Outside the U.S. Segment is still expected near the lower end of a 3% to 7% range. Sales and Pipeline Year-to-date signed contract awards at December 31, 2022, totaled $481 million and contracts pending (awarded but unsigned) totaled $661 million. The book-to-bill ratio at December 31, 2022, was 2.2x calculated on trailing twelve month basis. The sales pipeline at December 31, 2022, totaled $30.5 billion, comprised of approximately $6.0 billion in proposals pending, $1.71 billion in proposals in preparation, and $22.8 billion in opportunities tracking. New work opportunities represent 74.5% of the total sales pipeline. Balance Sheet and Cash Flows At December 31, 2022, cash and cash equivalents totaled $63.1 million, and gross debt was $1.57 billion. The ratio of debt, net of allowed cash, to adjusted EBITDA for the quarter ended December 31, 2022, as calculated in accordance with our credit agreement, was 3.0x. This compares to 2.6x at September 30, 2022. For the first quarter of fiscal year 2023, cash used in operating activities totaled $134.7 million and free cash flow was an outflow of $150.4 million. Collections for the month of December were lower than expected, contributing to weaker cash flows and a high debt ratio at quarter end. DSO increased to 74 days as of December 31, 2022, reflecting what is expected to be a temporary increase to the target range of 60 to 70 days. In the month of January, improved collections enabled the company to repay approximately $75 million of debt. The company continues to prioritize debt reduction using its free cash flow. On January 6, 2023, our Board of Directors declared a quarterly cash dividend of $0.28 for each share of our common stock outstanding. The dividend is payable on February 28, 2023, to shareholders of record on February 15, 2023. Raising FY23 Guidance Maximus is raising fiscal year 2023 revenue and earnings guidance following passage of the Consolidated Appropriations Act, 2023 (omnibus spending bill), which directs states to resume Medicaid redeterminations on a prescribed timeline. The company now expects revenue to range between $4.85 billion and $5.0 billion, compared to prior revenue guidance of between $4.75 billion and $4.90 billion. Adjusted operating income is expected to range between $415 million and $440 million, compared to a previous range between $390 million and $415 million. Adjusted operating income excludes an estimated $94 million of expense for amortization of intangible assets. Adjusted diluted earnings per share is now expected to range between $4.00 and $4.30 per share, compared to prior adjusted diluted earnings guidance of between $3.70 and $4.00 per share. The company's guidance assumes that redetermination activities in the U.S. Services Segment phase in during the third quarter and make a full period contribution in the fourth quarter of fiscal year 2023. Free cash flow is still expected to range between $225 million and $275 million for fiscal year 2023 and reflects expected working capital increases as a result of higher revenue later in the fiscal year. The company forecasts a slight reduction to interest expense, now ranging between $85 million and $90 million, an effective income tax rate between 24.5% and 25.5%, and weighted average shares outstanding between 61.2 million and 61.3 million shares for fiscal year 2023. Conference Call and Webcast Information Maximus will host a conference call tomorrow, February 9, 2023, at 9:00 a.m. ET. Shareholders are invited to submit questions for management’s consideration by emailing IR@maximus.com up to one hour prior to the call. The call is open to the public and available by webcast or by phone at: 877.407.8289 (Domestic) / +1.201.689.8341 (International) For those unable to listen to the live call, a recording of the webcast will be available on investor.maximus.com. About Maximus As a leading strategic partner to governments across the globe, Maximus helps improve the delivery of public services amid complex technology, health, economic, environmental, and social challenges. With a deep understanding of program service delivery, acute insights that achieve operational excellence, and an extensive awareness of the needs of the people being served, our employees advance the critical missions of our partners. Maximus delivers innovative business process management, impactful consulting services, and technology solutions that provide improved outcomes for the public and higher levels of productivity and efficiency of government-sponsored programs. For more information, visit maximus.com. Non-GAAP Measures and Risk Factors This release refers to non-GAAP measures and other indicators, including organic growth, free cash flow, operating income and EPS adjusted for amortization of intangible assets, adjusted EBITDA, and other non-GAAP measures. A description of these non-GAAP measures, the reasons why we use and present them, and details as to how they are calculated are included in our earnings presentation and forthcoming Form 10-Q. The presentation of these non-GAAP numbers is not meant to be considered in isolation, nor as alternatives to cash flows from operations, revenue growth, or net income as measures of performance. These non-GAAP financial measures, as determined and presented by us, may not be comparable to related or similarly titled measures presented by other companies. Statements that are not historical facts, including statements about the company’s confidence and strategies, and the company’s expectations about revenues, results of operations, profitability, future contracts, market opportunities, market demand, or acceptance of the company’s products are forward-looking statements that involve risks and uncertainties. These risks could cause the Company’s actual results to differ materially from those indicated by such forward-looking statements. A summary of risk factors can be found in Item 1A, "Risk Factors" in our Annual Report on Form 10-K for the year ended September 30, 2022, which was filed with the Securities and Exchange Commission (SEC) on November 22, 2022. The Company's SEC reports are accessible on maximus.com. Maximus, Inc. Consolidated Statements of Operations (Unaudited) For the Three Months Ended December 31, 2022 December 31, 2021 (in thousands, except per share amounts) Revenue $ 1,249,246 $ 1,150,876 Cost of revenue 1,004,499 922,721 Gross profit 244,747 228,155 Selling, general, and administrative expenses 146,452 124,221 Amortization of intangible assets 23,518 22,405 Operating income 74,777 81,529 Interest expense 21,606 9,638 Other income/(expense), net 266 (311 ) Income before income taxes 53,437 71,580 Provision for income taxes 13,442 18,250 Net income $ 39,995 $ 53,330 Earnings per share: Basic $ 0.65 $ 0.86 Diluted $ 0.65 $ 0.85 Weighted average shares outstanding: Basic 61,117 62,262 Diluted 61,196 62,445 Dividends declared per share $ 0.28 $ 0.28 Maximus, Inc. Consolidated Balance Sheets December 31, 2022 September 30, 2022 (unaudited) (in thousands) Assets: Cash and cash equivalents $ 63,050 $ 40,658 Accounts receivable, net 1,014,046 807,110 Income taxes receivable 4,486 2,158 Prepaid expenses and other current assets 174,505 182,387 Total current assets 1,256,087 1,032,313 Property and equipment, net 50,181 52,258 Capitalized software, net 64,963 58,740 Operating lease right-of-use assets 162,289 132,885 Goodwill 1,783,239 1,779,415 Intangible assets, net 782,821 804,904 Deferred contract costs, net 49,030 47,732 Deferred compensation plan assets 39,606 37,050 Deferred income taxes 5,038 4,970 Other assets 41,661 42,447 Total assets $ 4,234,915 $ 3,992,714 Liabilities and Shareholders' Equity: Liabilities: Accounts payable and accrued liabilities $ 272,196 $ 264,553 Accrued compensation and benefits 118,505 178,199 Deferred revenue, current portion 96,201 87,146 Income taxes payable 12,422 718 Long-term debt, current portion 77,479 63,458 Operating lease liabilities, current portion 59,553 63,999 Other current liabilities 109,866 116,374 Total current liabilities 746,222 774,447 Deferred revenue, non-current portion 29,624 21,414 Deferred income taxes 203,545 206,099 Long-term debt, non-current portion 1,486,975 1,292,483 Deferred compensation plan liabilities, non-current portion 44,688 40,210 Operating lease liabilities, non-current portion 119,081 86,175 Other liabilities 23,773 22,515 Total liabilities 2,653,908 2,443,343 Shareholders' equity: Common stock, no par value; 100,000 shares authorized; 60,774 issued and outstanding as of December 31, 2022 and September 30 2022, respectively (shares in thousands) 562,679 557,978 Accumulated other comprehensive loss (29,706 ) (33,961 ) Retained earnings 1,048,034 1,025,354 Total shareholders' equity 1,581,007 1,549,371 Total liabilities and shareholders' equity $ 4,234,915 $ 3,992,714 Maximus, Inc. Consolidated Statements of Cash Flows (Unaudited) For the Three Months Ended December 31, 2022 December 31, 2021 (in thousands) Cash flows from operating activities: Net income $ 39,995 $ 53,330 Adjustments to reconcile net income to cash flows from operations: Depreciation and amortization of property, equipment and capitalized software 12,280 11,365 Amortization of intangible assets 23,518 22,405 Amortization of debt issuance costs and debt discount 1,034 649 Deferred income taxes (1,331 ) (229 ) Stock compensation expense 4,403 8,248 Change in assets and liabilities, net of effects of business combinations: Accounts receivable (200,749 ) (14,114 ) Prepaid expenses and other current assets 10,624 (5,115 ) Deferred contract costs (1,013 ) (6,811 ) Accounts payable and accrued liabilities 3,642 (32,452 ) Accrued compensation and benefits (53,271 ) (56,305 ) Deferred revenue 14,764 5,929 Income taxes 9,465 10,321 Operating lease right-of-use assets and liabilities (948 ) (6,370 ) Other assets and liabilities 2,928 6,230 Net cash used in operating activities (134,659 ) (2,919 ) Cash flows from investing activities: Purchases of property and equipment and capitalized software (15,697 ) (6,327 ) Net cash used in investing activities (15,697 ) (6,327 ) Cash flows from financing activities: Cash dividends paid to Maximus shareholders (17,017 ) (17,347 ) Purchases of Maximus common stock — (1,379 ) Tax withholding related to RSU vesting (8,475 ) (9,673 ) Payments for contingent consideration (1,415 ) — Proceeds from borrowings 268,702 100,000 Principal payments for debt (61,355 ) (16,685 ) Restricted cash movements (9,473 ) — Net cash provided by financing activities 170,967 54,916 Effect of exchange rate changes on cash, cash equivalents, and restricted cash 2,421 372 Net change in cash, cash equivalents, and restricted cash 23,032 46,042 Cash, cash equivalents and restricted cash, beginning of period 136,795 156,570 Cash, cash equivalents and restricted cash, end of period $ 159,827 $ 202,612 Maximus, Inc. Consolidated Results of Operations by Segment (Unaudited) For the Three Months Ended December 31, 2022 December 31, 2021 Amount % (1) Amount % (1) (dollars in thousands) Revenue: U.S. Federal Services $ 618,167 $ 581,871 U.S. Services 439,478 386,417 Outside the U.S. 191,601 182,588 Revenue $ 1,249,246 $ 1,150,876 Gross profit: U.S. Federal Services $ 122,694 19.8 % $ 126,576 21.8 % U.S. Services 83,598 19.0 % 89,699 23.2 % Outside the U.S. 38,455 20.1 % 11,880 6.5 % Gross profit $ 244,747 19.6 % $ 228,155 19.8 % Selling, general, and administrative expenses: U.S. Federal Services $ 71,649 11.6 % $ 64,925 11.2 % U.S. Services 45,842 10.4 % 35,102 9.1 % Outside the U.S. 28,389 14.8 % 21,340 11.7 % Other (2) 572 NM 2,854 NM Selling, general, and administrative expenses $ 146,452 11.7 % $ 124,221 10.8 % Operating income: U.S. Federal Services $ 51,045 8.3 % $ 61,651 10.6 % U.S. Services 37,756 8.6 % 54,597 14.1 % Outside the U.S. 10,066 5.3 % (9,460 ) (5.2 )% Amortization of intangible assets (23,518 ) NM (22,405 ) NM Other (2) (572 ) NM (2,854 ) NM Operating income $ 74,777 6.0 % $ 81,529 7.1 % (1) Percentage of respective segment revenue. Percentages not considered meaningful are marked "NM." (2) Other expenses includes credits and costs that are not allocated to a particular segment. This includes expenses incurred as part of our acquisitions, as well as potential acquisitions which have not been or may not be completed. Maximus, Inc. Consolidated Free Cash Flows - Non-GAAP (Unaudited) For the Three Months Ended December 31, 2022 December 31, 2021 (in thousands) Net cash used in operating activities (134,659 ) (2,919 ) Purchases of property and equipment and capitalized software (15,697 ) (6,327 ) Free cash flow $ (150,356 ) $ (9,246 ) Maximus, Inc. Non-GAAP Adjusted Results Excluding Amortization of Intangible Assets (Unaudited) For the Three Months Ended December 31, 2022 December 31, 2021 (dollars in thousands, except per share data) Operating income $ 74,777 $ 81,529 Add back: Amortization of intangible assets 23,518 22,405 Adjusted operating income excluding amortization of intangible assets (Non-GAAP) $ 98,295 $ 103,934 Adjusted operating income margin excluding amortization of intangible assets (Non-GAAP) 7.9 % 9.0 % Net income $ 39,995 $ 53,330 Add back: Amortization of intangible assets, net of tax 17,360 16,530 Adjusted net income excluding amortization of intangible assets (Non-GAAP) $ 57,355 $ 69,860 Diluted earnings per share $ 0.65 $ 0.85 Add back: Effect of amortization of intangible assets on diluted earnings per share 0.29 0.27 Adjusted diluted earnings per share excluding amortization of intangible assets (Non-GAAP) $ 0.94 $ 1.12 View source version on businesswire.com: https://www.businesswire.com/news/home/20230208005798/en/Contacts James Francis, VP - IR Jessica Batt, VP - IR & ESG IR@maximus.com Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Maximus Reports Fiscal Year 2023 First Quarter Results By: Maximus via Business Wire February 08, 2023 at 16:05 PM EST Raises FY23 Revenue and Earnings Guidance Following Scheduled Restart of Medicaid Redeterminations Maximus (NYSE: MMS), a leading provider of government services worldwide, reported financial results for the three months ended December 31, 2022. Highlights for the first quarter of fiscal year 2023 include: Revenue increased 8.5% to $1.25 billion, compared to $1.15 billion for the prior year period. Organic growth was 10.3% and driven by new or expanded programs in all three segments. Diluted earnings per share were $0.65, and adjusted diluted earnings per share were $0.94. The company is raising revenue and earnings guidance for fiscal year 2023 following the restart of Medicaid redeterminations scheduled to begin in the third quarter. Fiscal year 2023 revenue is now expected to range between $4.85 billion and $5.0 billion with adjusted diluted earnings per share between $4.00 and $4.30 per share. A quarterly cash dividend of $0.28 per share is payable on February 28, 2023, to shareholders of record on February 15, 2023. "We are pleased with our solid first quarter results which reflect good execution, and we expect continued momentum in fiscal 2023," said Bruce Caswell, President and Chief Executive Officer. "Our increased guidance for fiscal 2023 is significant as it represents a clearing of the last remaining pandemic-related headwind in our U.S. Services business. Restarting Medicaid redeterminations is an unprecedented undertaking and as a long-term public partner to government, we are poised to support our current customers and see solid demand for our capabilities across the broader Medicaid market." Caswell continued, "We are capitalizing on the organic growth potential of the core business and executing well on our recently refreshed strategy, including making definitive headway in the key areas of clinical services and technology modernization. The remainder of fiscal year 2023, underpinned by our stable business model, should see us continue to successfully capture the upside potential of in-demand government services." First Quarter Results Revenue for the first quarter of fiscal year 2023 increased 8.5% to $1.25 billion, compared to $1.15 billion for the prior year period, which was net of a 1.9% currency headwind. Organic growth was 10.3% from new or expanded programs in all three segments resulting from strong demand for the company's services. For the first quarter of fiscal year 2023, operating margin was 6.0% and the adjusted operating margin was 7.9%. This compares to margins of 7.1% and 9.0%, respectively, for the prior year period. Diluted earnings per share were $0.65 and adjusted diluted earnings per share were $0.94. This compares to $0.85 and $1.12, respectively, for the prior-year period which contained profitable short-term COVID response work in the domestic segments and had less interest expense due to a more favorable rate environment. U.S. Federal Services Segment U.S. Federal Services Segment revenue for the first quarter of fiscal year 2023 increased 6.2% to $618.2 million, compared to $581.9 million reported for the prior year period. All growth was organic and driven primarily by volume growth in the segment's clinical services business and an anticipated higher run rate on a large cost-plus contract. The segment operating margin for the first quarter of fiscal year 2023 was 8.3%, compared to 10.6% reported for the prior year, and in-line with company expectations. The full-year fiscal 2023 margin for the U.S. Federal Services Segment is still expected to range between 10% and 11%. U.S. Services Segment U.S. Services Segment revenue for the first quarter of fiscal year 2023 increased 13.7% to $439.5 million, compared to $386.4 million reported in the prior year period. All growth was organic and driven by previously disclosed new work in the core business areas of eligibility support and clinical services. The segment operating margin for the first quarter of fiscal year 2023 was 8.6%, compared to 14.1% reported for the prior year period, reflecting the headwind to the segment's profitability from the paused Medicaid redeterminations. The full-year fiscal 2023 margin for the U.S. Services Segment is expected to range between 9% and 11% with a lift to profitability expected later in the fiscal year due to the scheduled restart of redeterminations. Outside the U.S. Segment Outside the U.S. Segment revenue for the first quarter of fiscal year 2023 increased 4.9% to $191.6 million, compared to $182.6 million reported in the prior year period, which was net of a 12% currency headwind. Organic growth in the segment was approximately 16% driven primarily by the U.K. Restart Programme reaching full capacity. The segment operating income for the first quarter of fiscal year 2023 was $10.1 million, or 5.3% on a margin basis. This compares to an operating loss of $9.5 million in the prior year period due primarily to contracts with planned start-up losses, such as the U.K. Restart Programme. The full-year fiscal 2023 margin for Outside the U.S. Segment is still expected near the lower end of a 3% to 7% range. Sales and Pipeline Year-to-date signed contract awards at December 31, 2022, totaled $481 million and contracts pending (awarded but unsigned) totaled $661 million. The book-to-bill ratio at December 31, 2022, was 2.2x calculated on trailing twelve month basis. The sales pipeline at December 31, 2022, totaled $30.5 billion, comprised of approximately $6.0 billion in proposals pending, $1.71 billion in proposals in preparation, and $22.8 billion in opportunities tracking. New work opportunities represent 74.5% of the total sales pipeline. Balance Sheet and Cash Flows At December 31, 2022, cash and cash equivalents totaled $63.1 million, and gross debt was $1.57 billion. The ratio of debt, net of allowed cash, to adjusted EBITDA for the quarter ended December 31, 2022, as calculated in accordance with our credit agreement, was 3.0x. This compares to 2.6x at September 30, 2022. For the first quarter of fiscal year 2023, cash used in operating activities totaled $134.7 million and free cash flow was an outflow of $150.4 million. Collections for the month of December were lower than expected, contributing to weaker cash flows and a high debt ratio at quarter end. DSO increased to 74 days as of December 31, 2022, reflecting what is expected to be a temporary increase to the target range of 60 to 70 days. In the month of January, improved collections enabled the company to repay approximately $75 million of debt. The company continues to prioritize debt reduction using its free cash flow. On January 6, 2023, our Board of Directors declared a quarterly cash dividend of $0.28 for each share of our common stock outstanding. The dividend is payable on February 28, 2023, to shareholders of record on February 15, 2023. Raising FY23 Guidance Maximus is raising fiscal year 2023 revenue and earnings guidance following passage of the Consolidated Appropriations Act, 2023 (omnibus spending bill), which directs states to resume Medicaid redeterminations on a prescribed timeline. The company now expects revenue to range between $4.85 billion and $5.0 billion, compared to prior revenue guidance of between $4.75 billion and $4.90 billion. Adjusted operating income is expected to range between $415 million and $440 million, compared to a previous range between $390 million and $415 million. Adjusted operating income excludes an estimated $94 million of expense for amortization of intangible assets. Adjusted diluted earnings per share is now expected to range between $4.00 and $4.30 per share, compared to prior adjusted diluted earnings guidance of between $3.70 and $4.00 per share. The company's guidance assumes that redetermination activities in the U.S. Services Segment phase in during the third quarter and make a full period contribution in the fourth quarter of fiscal year 2023. Free cash flow is still expected to range between $225 million and $275 million for fiscal year 2023 and reflects expected working capital increases as a result of higher revenue later in the fiscal year. The company forecasts a slight reduction to interest expense, now ranging between $85 million and $90 million, an effective income tax rate between 24.5% and 25.5%, and weighted average shares outstanding between 61.2 million and 61.3 million shares for fiscal year 2023. Conference Call and Webcast Information Maximus will host a conference call tomorrow, February 9, 2023, at 9:00 a.m. ET. Shareholders are invited to submit questions for management’s consideration by emailing IR@maximus.com up to one hour prior to the call. The call is open to the public and available by webcast or by phone at: 877.407.8289 (Domestic) / +1.201.689.8341 (International) For those unable to listen to the live call, a recording of the webcast will be available on investor.maximus.com. About Maximus As a leading strategic partner to governments across the globe, Maximus helps improve the delivery of public services amid complex technology, health, economic, environmental, and social challenges. With a deep understanding of program service delivery, acute insights that achieve operational excellence, and an extensive awareness of the needs of the people being served, our employees advance the critical missions of our partners. Maximus delivers innovative business process management, impactful consulting services, and technology solutions that provide improved outcomes for the public and higher levels of productivity and efficiency of government-sponsored programs. For more information, visit maximus.com. Non-GAAP Measures and Risk Factors This release refers to non-GAAP measures and other indicators, including organic growth, free cash flow, operating income and EPS adjusted for amortization of intangible assets, adjusted EBITDA, and other non-GAAP measures. A description of these non-GAAP measures, the reasons why we use and present them, and details as to how they are calculated are included in our earnings presentation and forthcoming Form 10-Q. The presentation of these non-GAAP numbers is not meant to be considered in isolation, nor as alternatives to cash flows from operations, revenue growth, or net income as measures of performance. These non-GAAP financial measures, as determined and presented by us, may not be comparable to related or similarly titled measures presented by other companies. Statements that are not historical facts, including statements about the company’s confidence and strategies, and the company’s expectations about revenues, results of operations, profitability, future contracts, market opportunities, market demand, or acceptance of the company’s products are forward-looking statements that involve risks and uncertainties. These risks could cause the Company’s actual results to differ materially from those indicated by such forward-looking statements. A summary of risk factors can be found in Item 1A, "Risk Factors" in our Annual Report on Form 10-K for the year ended September 30, 2022, which was filed with the Securities and Exchange Commission (SEC) on November 22, 2022. The Company's SEC reports are accessible on maximus.com. Maximus, Inc. Consolidated Statements of Operations (Unaudited) For the Three Months Ended December 31, 2022 December 31, 2021 (in thousands, except per share amounts) Revenue $ 1,249,246 $ 1,150,876 Cost of revenue 1,004,499 922,721 Gross profit 244,747 228,155 Selling, general, and administrative expenses 146,452 124,221 Amortization of intangible assets 23,518 22,405 Operating income 74,777 81,529 Interest expense 21,606 9,638 Other income/(expense), net 266 (311 ) Income before income taxes 53,437 71,580 Provision for income taxes 13,442 18,250 Net income $ 39,995 $ 53,330 Earnings per share: Basic $ 0.65 $ 0.86 Diluted $ 0.65 $ 0.85 Weighted average shares outstanding: Basic 61,117 62,262 Diluted 61,196 62,445 Dividends declared per share $ 0.28 $ 0.28 Maximus, Inc. Consolidated Balance Sheets December 31, 2022 September 30, 2022 (unaudited) (in thousands) Assets: Cash and cash equivalents $ 63,050 $ 40,658 Accounts receivable, net 1,014,046 807,110 Income taxes receivable 4,486 2,158 Prepaid expenses and other current assets 174,505 182,387 Total current assets 1,256,087 1,032,313 Property and equipment, net 50,181 52,258 Capitalized software, net 64,963 58,740 Operating lease right-of-use assets 162,289 132,885 Goodwill 1,783,239 1,779,415 Intangible assets, net 782,821 804,904 Deferred contract costs, net 49,030 47,732 Deferred compensation plan assets 39,606 37,050 Deferred income taxes 5,038 4,970 Other assets 41,661 42,447 Total assets $ 4,234,915 $ 3,992,714 Liabilities and Shareholders' Equity: Liabilities: Accounts payable and accrued liabilities $ 272,196 $ 264,553 Accrued compensation and benefits 118,505 178,199 Deferred revenue, current portion 96,201 87,146 Income taxes payable 12,422 718 Long-term debt, current portion 77,479 63,458 Operating lease liabilities, current portion 59,553 63,999 Other current liabilities 109,866 116,374 Total current liabilities 746,222 774,447 Deferred revenue, non-current portion 29,624 21,414 Deferred income taxes 203,545 206,099 Long-term debt, non-current portion 1,486,975 1,292,483 Deferred compensation plan liabilities, non-current portion 44,688 40,210 Operating lease liabilities, non-current portion 119,081 86,175 Other liabilities 23,773 22,515 Total liabilities 2,653,908 2,443,343 Shareholders' equity: Common stock, no par value; 100,000 shares authorized; 60,774 issued and outstanding as of December 31, 2022 and September 30 2022, respectively (shares in thousands) 562,679 557,978 Accumulated other comprehensive loss (29,706 ) (33,961 ) Retained earnings 1,048,034 1,025,354 Total shareholders' equity 1,581,007 1,549,371 Total liabilities and shareholders' equity $ 4,234,915 $ 3,992,714 Maximus, Inc. Consolidated Statements of Cash Flows (Unaudited) For the Three Months Ended December 31, 2022 December 31, 2021 (in thousands) Cash flows from operating activities: Net income $ 39,995 $ 53,330 Adjustments to reconcile net income to cash flows from operations: Depreciation and amortization of property, equipment and capitalized software 12,280 11,365 Amortization of intangible assets 23,518 22,405 Amortization of debt issuance costs and debt discount 1,034 649 Deferred income taxes (1,331 ) (229 ) Stock compensation expense 4,403 8,248 Change in assets and liabilities, net of effects of business combinations: Accounts receivable (200,749 ) (14,114 ) Prepaid expenses and other current assets 10,624 (5,115 ) Deferred contract costs (1,013 ) (6,811 ) Accounts payable and accrued liabilities 3,642 (32,452 ) Accrued compensation and benefits (53,271 ) (56,305 ) Deferred revenue 14,764 5,929 Income taxes 9,465 10,321 Operating lease right-of-use assets and liabilities (948 ) (6,370 ) Other assets and liabilities 2,928 6,230 Net cash used in operating activities (134,659 ) (2,919 ) Cash flows from investing activities: Purchases of property and equipment and capitalized software (15,697 ) (6,327 ) Net cash used in investing activities (15,697 ) (6,327 ) Cash flows from financing activities: Cash dividends paid to Maximus shareholders (17,017 ) (17,347 ) Purchases of Maximus common stock — (1,379 ) Tax withholding related to RSU vesting (8,475 ) (9,673 ) Payments for contingent consideration (1,415 ) — Proceeds from borrowings 268,702 100,000 Principal payments for debt (61,355 ) (16,685 ) Restricted cash movements (9,473 ) — Net cash provided by financing activities 170,967 54,916 Effect of exchange rate changes on cash, cash equivalents, and restricted cash 2,421 372 Net change in cash, cash equivalents, and restricted cash 23,032 46,042 Cash, cash equivalents and restricted cash, beginning of period 136,795 156,570 Cash, cash equivalents and restricted cash, end of period $ 159,827 $ 202,612 Maximus, Inc. Consolidated Results of Operations by Segment (Unaudited) For the Three Months Ended December 31, 2022 December 31, 2021 Amount % (1) Amount % (1) (dollars in thousands) Revenue: U.S. Federal Services $ 618,167 $ 581,871 U.S. Services 439,478 386,417 Outside the U.S. 191,601 182,588 Revenue $ 1,249,246 $ 1,150,876 Gross profit: U.S. Federal Services $ 122,694 19.8 % $ 126,576 21.8 % U.S. Services 83,598 19.0 % 89,699 23.2 % Outside the U.S. 38,455 20.1 % 11,880 6.5 % Gross profit $ 244,747 19.6 % $ 228,155 19.8 % Selling, general, and administrative expenses: U.S. Federal Services $ 71,649 11.6 % $ 64,925 11.2 % U.S. Services 45,842 10.4 % 35,102 9.1 % Outside the U.S. 28,389 14.8 % 21,340 11.7 % Other (2) 572 NM 2,854 NM Selling, general, and administrative expenses $ 146,452 11.7 % $ 124,221 10.8 % Operating income: U.S. Federal Services $ 51,045 8.3 % $ 61,651 10.6 % U.S. Services 37,756 8.6 % 54,597 14.1 % Outside the U.S. 10,066 5.3 % (9,460 ) (5.2 )% Amortization of intangible assets (23,518 ) NM (22,405 ) NM Other (2) (572 ) NM (2,854 ) NM Operating income $ 74,777 6.0 % $ 81,529 7.1 % (1) Percentage of respective segment revenue. Percentages not considered meaningful are marked "NM." (2) Other expenses includes credits and costs that are not allocated to a particular segment. This includes expenses incurred as part of our acquisitions, as well as potential acquisitions which have not been or may not be completed. Maximus, Inc. Consolidated Free Cash Flows - Non-GAAP (Unaudited) For the Three Months Ended December 31, 2022 December 31, 2021 (in thousands) Net cash used in operating activities (134,659 ) (2,919 ) Purchases of property and equipment and capitalized software (15,697 ) (6,327 ) Free cash flow $ (150,356 ) $ (9,246 ) Maximus, Inc. Non-GAAP Adjusted Results Excluding Amortization of Intangible Assets (Unaudited) For the Three Months Ended December 31, 2022 December 31, 2021 (dollars in thousands, except per share data) Operating income $ 74,777 $ 81,529 Add back: Amortization of intangible assets 23,518 22,405 Adjusted operating income excluding amortization of intangible assets (Non-GAAP) $ 98,295 $ 103,934 Adjusted operating income margin excluding amortization of intangible assets (Non-GAAP) 7.9 % 9.0 % Net income $ 39,995 $ 53,330 Add back: Amortization of intangible assets, net of tax 17,360 16,530 Adjusted net income excluding amortization of intangible assets (Non-GAAP) $ 57,355 $ 69,860 Diluted earnings per share $ 0.65 $ 0.85 Add back: Effect of amortization of intangible assets on diluted earnings per share 0.29 0.27 Adjusted diluted earnings per share excluding amortization of intangible assets (Non-GAAP) $ 0.94 $ 1.12 View source version on businesswire.com: https://www.businesswire.com/news/home/20230208005798/en/Contacts James Francis, VP - IR Jessica Batt, VP - IR & ESG IR@maximus.com
Maximus (NYSE: MMS), a leading provider of government services worldwide, reported financial results for the three months ended December 31, 2022. Highlights for the first quarter of fiscal year 2023 include: Revenue increased 8.5% to $1.25 billion, compared to $1.15 billion for the prior year period. Organic growth was 10.3% and driven by new or expanded programs in all three segments. Diluted earnings per share were $0.65, and adjusted diluted earnings per share were $0.94. The company is raising revenue and earnings guidance for fiscal year 2023 following the restart of Medicaid redeterminations scheduled to begin in the third quarter. Fiscal year 2023 revenue is now expected to range between $4.85 billion and $5.0 billion with adjusted diluted earnings per share between $4.00 and $4.30 per share. A quarterly cash dividend of $0.28 per share is payable on February 28, 2023, to shareholders of record on February 15, 2023. "We are pleased with our solid first quarter results which reflect good execution, and we expect continued momentum in fiscal 2023," said Bruce Caswell, President and Chief Executive Officer. "Our increased guidance for fiscal 2023 is significant as it represents a clearing of the last remaining pandemic-related headwind in our U.S. Services business. Restarting Medicaid redeterminations is an unprecedented undertaking and as a long-term public partner to government, we are poised to support our current customers and see solid demand for our capabilities across the broader Medicaid market." Caswell continued, "We are capitalizing on the organic growth potential of the core business and executing well on our recently refreshed strategy, including making definitive headway in the key areas of clinical services and technology modernization. The remainder of fiscal year 2023, underpinned by our stable business model, should see us continue to successfully capture the upside potential of in-demand government services." First Quarter Results Revenue for the first quarter of fiscal year 2023 increased 8.5% to $1.25 billion, compared to $1.15 billion for the prior year period, which was net of a 1.9% currency headwind. Organic growth was 10.3% from new or expanded programs in all three segments resulting from strong demand for the company's services. For the first quarter of fiscal year 2023, operating margin was 6.0% and the adjusted operating margin was 7.9%. This compares to margins of 7.1% and 9.0%, respectively, for the prior year period. Diluted earnings per share were $0.65 and adjusted diluted earnings per share were $0.94. This compares to $0.85 and $1.12, respectively, for the prior-year period which contained profitable short-term COVID response work in the domestic segments and had less interest expense due to a more favorable rate environment. U.S. Federal Services Segment U.S. Federal Services Segment revenue for the first quarter of fiscal year 2023 increased 6.2% to $618.2 million, compared to $581.9 million reported for the prior year period. All growth was organic and driven primarily by volume growth in the segment's clinical services business and an anticipated higher run rate on a large cost-plus contract. The segment operating margin for the first quarter of fiscal year 2023 was 8.3%, compared to 10.6% reported for the prior year, and in-line with company expectations. The full-year fiscal 2023 margin for the U.S. Federal Services Segment is still expected to range between 10% and 11%. U.S. Services Segment U.S. Services Segment revenue for the first quarter of fiscal year 2023 increased 13.7% to $439.5 million, compared to $386.4 million reported in the prior year period. All growth was organic and driven by previously disclosed new work in the core business areas of eligibility support and clinical services. The segment operating margin for the first quarter of fiscal year 2023 was 8.6%, compared to 14.1% reported for the prior year period, reflecting the headwind to the segment's profitability from the paused Medicaid redeterminations. The full-year fiscal 2023 margin for the U.S. Services Segment is expected to range between 9% and 11% with a lift to profitability expected later in the fiscal year due to the scheduled restart of redeterminations. Outside the U.S. Segment Outside the U.S. Segment revenue for the first quarter of fiscal year 2023 increased 4.9% to $191.6 million, compared to $182.6 million reported in the prior year period, which was net of a 12% currency headwind. Organic growth in the segment was approximately 16% driven primarily by the U.K. Restart Programme reaching full capacity. The segment operating income for the first quarter of fiscal year 2023 was $10.1 million, or 5.3% on a margin basis. This compares to an operating loss of $9.5 million in the prior year period due primarily to contracts with planned start-up losses, such as the U.K. Restart Programme. The full-year fiscal 2023 margin for Outside the U.S. Segment is still expected near the lower end of a 3% to 7% range. Sales and Pipeline Year-to-date signed contract awards at December 31, 2022, totaled $481 million and contracts pending (awarded but unsigned) totaled $661 million. The book-to-bill ratio at December 31, 2022, was 2.2x calculated on trailing twelve month basis. The sales pipeline at December 31, 2022, totaled $30.5 billion, comprised of approximately $6.0 billion in proposals pending, $1.71 billion in proposals in preparation, and $22.8 billion in opportunities tracking. New work opportunities represent 74.5% of the total sales pipeline. Balance Sheet and Cash Flows At December 31, 2022, cash and cash equivalents totaled $63.1 million, and gross debt was $1.57 billion. The ratio of debt, net of allowed cash, to adjusted EBITDA for the quarter ended December 31, 2022, as calculated in accordance with our credit agreement, was 3.0x. This compares to 2.6x at September 30, 2022. For the first quarter of fiscal year 2023, cash used in operating activities totaled $134.7 million and free cash flow was an outflow of $150.4 million. Collections for the month of December were lower than expected, contributing to weaker cash flows and a high debt ratio at quarter end. DSO increased to 74 days as of December 31, 2022, reflecting what is expected to be a temporary increase to the target range of 60 to 70 days. In the month of January, improved collections enabled the company to repay approximately $75 million of debt. The company continues to prioritize debt reduction using its free cash flow. On January 6, 2023, our Board of Directors declared a quarterly cash dividend of $0.28 for each share of our common stock outstanding. The dividend is payable on February 28, 2023, to shareholders of record on February 15, 2023. Raising FY23 Guidance Maximus is raising fiscal year 2023 revenue and earnings guidance following passage of the Consolidated Appropriations Act, 2023 (omnibus spending bill), which directs states to resume Medicaid redeterminations on a prescribed timeline. The company now expects revenue to range between $4.85 billion and $5.0 billion, compared to prior revenue guidance of between $4.75 billion and $4.90 billion. Adjusted operating income is expected to range between $415 million and $440 million, compared to a previous range between $390 million and $415 million. Adjusted operating income excludes an estimated $94 million of expense for amortization of intangible assets. Adjusted diluted earnings per share is now expected to range between $4.00 and $4.30 per share, compared to prior adjusted diluted earnings guidance of between $3.70 and $4.00 per share. The company's guidance assumes that redetermination activities in the U.S. Services Segment phase in during the third quarter and make a full period contribution in the fourth quarter of fiscal year 2023. Free cash flow is still expected to range between $225 million and $275 million for fiscal year 2023 and reflects expected working capital increases as a result of higher revenue later in the fiscal year. The company forecasts a slight reduction to interest expense, now ranging between $85 million and $90 million, an effective income tax rate between 24.5% and 25.5%, and weighted average shares outstanding between 61.2 million and 61.3 million shares for fiscal year 2023. Conference Call and Webcast Information Maximus will host a conference call tomorrow, February 9, 2023, at 9:00 a.m. ET. Shareholders are invited to submit questions for management’s consideration by emailing IR@maximus.com up to one hour prior to the call. The call is open to the public and available by webcast or by phone at: 877.407.8289 (Domestic) / +1.201.689.8341 (International) For those unable to listen to the live call, a recording of the webcast will be available on investor.maximus.com. About Maximus As a leading strategic partner to governments across the globe, Maximus helps improve the delivery of public services amid complex technology, health, economic, environmental, and social challenges. With a deep understanding of program service delivery, acute insights that achieve operational excellence, and an extensive awareness of the needs of the people being served, our employees advance the critical missions of our partners. Maximus delivers innovative business process management, impactful consulting services, and technology solutions that provide improved outcomes for the public and higher levels of productivity and efficiency of government-sponsored programs. For more information, visit maximus.com. Non-GAAP Measures and Risk Factors This release refers to non-GAAP measures and other indicators, including organic growth, free cash flow, operating income and EPS adjusted for amortization of intangible assets, adjusted EBITDA, and other non-GAAP measures. A description of these non-GAAP measures, the reasons why we use and present them, and details as to how they are calculated are included in our earnings presentation and forthcoming Form 10-Q. The presentation of these non-GAAP numbers is not meant to be considered in isolation, nor as alternatives to cash flows from operations, revenue growth, or net income as measures of performance. These non-GAAP financial measures, as determined and presented by us, may not be comparable to related or similarly titled measures presented by other companies. Statements that are not historical facts, including statements about the company’s confidence and strategies, and the company’s expectations about revenues, results of operations, profitability, future contracts, market opportunities, market demand, or acceptance of the company’s products are forward-looking statements that involve risks and uncertainties. These risks could cause the Company’s actual results to differ materially from those indicated by such forward-looking statements. A summary of risk factors can be found in Item 1A, "Risk Factors" in our Annual Report on Form 10-K for the year ended September 30, 2022, which was filed with the Securities and Exchange Commission (SEC) on November 22, 2022. The Company's SEC reports are accessible on maximus.com. Maximus, Inc. Consolidated Statements of Operations (Unaudited) For the Three Months Ended December 31, 2022 December 31, 2021 (in thousands, except per share amounts) Revenue $ 1,249,246 $ 1,150,876 Cost of revenue 1,004,499 922,721 Gross profit 244,747 228,155 Selling, general, and administrative expenses 146,452 124,221 Amortization of intangible assets 23,518 22,405 Operating income 74,777 81,529 Interest expense 21,606 9,638 Other income/(expense), net 266 (311 ) Income before income taxes 53,437 71,580 Provision for income taxes 13,442 18,250 Net income $ 39,995 $ 53,330 Earnings per share: Basic $ 0.65 $ 0.86 Diluted $ 0.65 $ 0.85 Weighted average shares outstanding: Basic 61,117 62,262 Diluted 61,196 62,445 Dividends declared per share $ 0.28 $ 0.28 Maximus, Inc. Consolidated Balance Sheets December 31, 2022 September 30, 2022 (unaudited) (in thousands) Assets: Cash and cash equivalents $ 63,050 $ 40,658 Accounts receivable, net 1,014,046 807,110 Income taxes receivable 4,486 2,158 Prepaid expenses and other current assets 174,505 182,387 Total current assets 1,256,087 1,032,313 Property and equipment, net 50,181 52,258 Capitalized software, net 64,963 58,740 Operating lease right-of-use assets 162,289 132,885 Goodwill 1,783,239 1,779,415 Intangible assets, net 782,821 804,904 Deferred contract costs, net 49,030 47,732 Deferred compensation plan assets 39,606 37,050 Deferred income taxes 5,038 4,970 Other assets 41,661 42,447 Total assets $ 4,234,915 $ 3,992,714 Liabilities and Shareholders' Equity: Liabilities: Accounts payable and accrued liabilities $ 272,196 $ 264,553 Accrued compensation and benefits 118,505 178,199 Deferred revenue, current portion 96,201 87,146 Income taxes payable 12,422 718 Long-term debt, current portion 77,479 63,458 Operating lease liabilities, current portion 59,553 63,999 Other current liabilities 109,866 116,374 Total current liabilities 746,222 774,447 Deferred revenue, non-current portion 29,624 21,414 Deferred income taxes 203,545 206,099 Long-term debt, non-current portion 1,486,975 1,292,483 Deferred compensation plan liabilities, non-current portion 44,688 40,210 Operating lease liabilities, non-current portion 119,081 86,175 Other liabilities 23,773 22,515 Total liabilities 2,653,908 2,443,343 Shareholders' equity: Common stock, no par value; 100,000 shares authorized; 60,774 issued and outstanding as of December 31, 2022 and September 30 2022, respectively (shares in thousands) 562,679 557,978 Accumulated other comprehensive loss (29,706 ) (33,961 ) Retained earnings 1,048,034 1,025,354 Total shareholders' equity 1,581,007 1,549,371 Total liabilities and shareholders' equity $ 4,234,915 $ 3,992,714 Maximus, Inc. Consolidated Statements of Cash Flows (Unaudited) For the Three Months Ended December 31, 2022 December 31, 2021 (in thousands) Cash flows from operating activities: Net income $ 39,995 $ 53,330 Adjustments to reconcile net income to cash flows from operations: Depreciation and amortization of property, equipment and capitalized software 12,280 11,365 Amortization of intangible assets 23,518 22,405 Amortization of debt issuance costs and debt discount 1,034 649 Deferred income taxes (1,331 ) (229 ) Stock compensation expense 4,403 8,248 Change in assets and liabilities, net of effects of business combinations: Accounts receivable (200,749 ) (14,114 ) Prepaid expenses and other current assets 10,624 (5,115 ) Deferred contract costs (1,013 ) (6,811 ) Accounts payable and accrued liabilities 3,642 (32,452 ) Accrued compensation and benefits (53,271 ) (56,305 ) Deferred revenue 14,764 5,929 Income taxes 9,465 10,321 Operating lease right-of-use assets and liabilities (948 ) (6,370 ) Other assets and liabilities 2,928 6,230 Net cash used in operating activities (134,659 ) (2,919 ) Cash flows from investing activities: Purchases of property and equipment and capitalized software (15,697 ) (6,327 ) Net cash used in investing activities (15,697 ) (6,327 ) Cash flows from financing activities: Cash dividends paid to Maximus shareholders (17,017 ) (17,347 ) Purchases of Maximus common stock — (1,379 ) Tax withholding related to RSU vesting (8,475 ) (9,673 ) Payments for contingent consideration (1,415 ) — Proceeds from borrowings 268,702 100,000 Principal payments for debt (61,355 ) (16,685 ) Restricted cash movements (9,473 ) — Net cash provided by financing activities 170,967 54,916 Effect of exchange rate changes on cash, cash equivalents, and restricted cash 2,421 372 Net change in cash, cash equivalents, and restricted cash 23,032 46,042 Cash, cash equivalents and restricted cash, beginning of period 136,795 156,570 Cash, cash equivalents and restricted cash, end of period $ 159,827 $ 202,612 Maximus, Inc. Consolidated Results of Operations by Segment (Unaudited) For the Three Months Ended December 31, 2022 December 31, 2021 Amount % (1) Amount % (1) (dollars in thousands) Revenue: U.S. Federal Services $ 618,167 $ 581,871 U.S. Services 439,478 386,417 Outside the U.S. 191,601 182,588 Revenue $ 1,249,246 $ 1,150,876 Gross profit: U.S. Federal Services $ 122,694 19.8 % $ 126,576 21.8 % U.S. Services 83,598 19.0 % 89,699 23.2 % Outside the U.S. 38,455 20.1 % 11,880 6.5 % Gross profit $ 244,747 19.6 % $ 228,155 19.8 % Selling, general, and administrative expenses: U.S. Federal Services $ 71,649 11.6 % $ 64,925 11.2 % U.S. Services 45,842 10.4 % 35,102 9.1 % Outside the U.S. 28,389 14.8 % 21,340 11.7 % Other (2) 572 NM 2,854 NM Selling, general, and administrative expenses $ 146,452 11.7 % $ 124,221 10.8 % Operating income: U.S. Federal Services $ 51,045 8.3 % $ 61,651 10.6 % U.S. Services 37,756 8.6 % 54,597 14.1 % Outside the U.S. 10,066 5.3 % (9,460 ) (5.2 )% Amortization of intangible assets (23,518 ) NM (22,405 ) NM Other (2) (572 ) NM (2,854 ) NM Operating income $ 74,777 6.0 % $ 81,529 7.1 % (1) Percentage of respective segment revenue. Percentages not considered meaningful are marked "NM." (2) Other expenses includes credits and costs that are not allocated to a particular segment. This includes expenses incurred as part of our acquisitions, as well as potential acquisitions which have not been or may not be completed. Maximus, Inc. Consolidated Free Cash Flows - Non-GAAP (Unaudited) For the Three Months Ended December 31, 2022 December 31, 2021 (in thousands) Net cash used in operating activities (134,659 ) (2,919 ) Purchases of property and equipment and capitalized software (15,697 ) (6,327 ) Free cash flow $ (150,356 ) $ (9,246 ) Maximus, Inc. Non-GAAP Adjusted Results Excluding Amortization of Intangible Assets (Unaudited) For the Three Months Ended December 31, 2022 December 31, 2021 (dollars in thousands, except per share data) Operating income $ 74,777 $ 81,529 Add back: Amortization of intangible assets 23,518 22,405 Adjusted operating income excluding amortization of intangible assets (Non-GAAP) $ 98,295 $ 103,934 Adjusted operating income margin excluding amortization of intangible assets (Non-GAAP) 7.9 % 9.0 % Net income $ 39,995 $ 53,330 Add back: Amortization of intangible assets, net of tax 17,360 16,530 Adjusted net income excluding amortization of intangible assets (Non-GAAP) $ 57,355 $ 69,860 Diluted earnings per share $ 0.65 $ 0.85 Add back: Effect of amortization of intangible assets on diluted earnings per share 0.29 0.27 Adjusted diluted earnings per share excluding amortization of intangible assets (Non-GAAP) $ 0.94 $ 1.12 View source version on businesswire.com: https://www.businesswire.com/news/home/20230208005798/en/
